| __timestamp | Regeneron Pharmaceuticals, Inc. | Xencor, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 504755000 | 7461000 |
| Thursday, January 1, 2015 | 838526000 | 11960000 |
| Friday, January 1, 2016 | 1177697000 | 13108000 |
| Sunday, January 1, 2017 | 1320433000 | 17501000 |
| Monday, January 1, 2018 | 1556200000 | 22472000 |
| Tuesday, January 1, 2019 | 1834800000 | 24286000 |
| Wednesday, January 1, 2020 | 1346000000 | 29689000 |
| Friday, January 1, 2021 | 1824900000 | 38837000 |
| Saturday, January 1, 2022 | 2115900000 | 47489000 |
| Sunday, January 1, 2023 | 2631300000 | 53379000 |
| Monday, January 1, 2024 | 2954400000 |
Unlocking the unknown
In the competitive world of biotechnology, managing operational costs is crucial for sustained growth. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Regeneron Pharmaceuticals, Inc. and Xencor, Inc. from 2014 to 2023. Regeneron, a leader in the biotech industry, has seen its SG&A expenses grow by over 400% during this period, peaking at approximately $2.63 billion in 2023. In contrast, Xencor, a smaller player, experienced a more modest increase of around 615%, reaching $53.4 million in the same year.
This stark difference highlights the scale at which these companies operate. While Regeneron's expenses reflect its expansive operations and market reach, Xencor's growth in SG&A expenses indicates its strategic investments in scaling operations. Understanding these trends provides valuable insights into how these companies allocate resources to maintain their competitive edge.
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Summit Therapeutics Inc.
Regeneron Pharmaceuticals, Inc. vs Axsome Therapeutics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Regeneron Pharmaceuticals, Inc. and Cytokinetics, Incorporated
Breaking Down SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs ImmunityBio, Inc.
Operational Costs Compared: SG&A Analysis of Regeneron Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Regeneron Pharmaceuticals, Inc. and Geron Corporation: SG&A Spending Patterns Compared
Regeneron Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.: SG&A Expense Trends
Intra-Cellular Therapies, Inc. vs Xencor, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: TG Therapeutics, Inc. vs Xencor, Inc. Trends and Insights
Selling, General, and Administrative Costs: Xenon Pharmaceuticals Inc. vs Xencor, Inc.
SG&A Efficiency Analysis: Comparing Geron Corporation and Xencor, Inc.
Xencor, Inc. and Viridian Therapeutics, Inc.: SG&A Spending Patterns Compared